Multiple Sclerosis

Ongoing Review of DMTs Necessary Among Patients With Multiple Sclerosis

January 26th 2021, 8:09pm


Periodic review of treatment safety and monitoring are necessary as medical centers increasingly use newer disease-modifying therapies earlier in the course of multiple sclerosis.

Top 5 Most-Read Multiple Sclerosis Articles of 2020

December 27th 2020, 1:00pm


The coronavirus disease 2019 (COVID-19) pandemic dominated headlines for much of 2020, and most of the top 5 multiple sclerosis articles of this year discussed the effects of COVID-19 on patients with this disease. Others touched on physician and patient assessments of relapse and potential new treatments for neural damage.

Researchers Review Available Efficacy, Safety Data on Ozanimod in RMS

December 23rd 2020, 8:51pm


Researchers analyzed the available evidence on the treatment’s efficacy and safety profile from the RADIANCE and SUNBEAM trials.

SPMS Drug Linked to Improved Cognition Processing Speed, Study Says

December 19th 2020, 7:30pm


As a neurodegenerative disease, secondary progressive multiple sclerosis (SPMS) may lead to a degradation of cognition skills as the disease progresses.

Cytokine Biomarkers Can Diagnose Multiple Sclerosis, Study Suggests

December 16th 2020, 11:30pm


A new study indicates that an analysis of serum and cerebrospinal fluid cytokine levels can identify multiple sclerosis and its forms.

Researchers Examine MS Gender Differences in Direct, Indirect Costs

December 12th 2020, 11:45pm


The German multiple sclerosis (MS) study found differences by gender for some costs, but the overall economic burden of the disease was about the same.

Prevalence of Headache High in Patients With MS

December 12th 2020, 8:00pm


A recent review examines the prevalence of headache among patients with multiple sclerosis, particularly migraine.

Study Probes Effect of Shared Decision-Making on MS Care in The Netherlands

December 5th 2020, 6:15pm


The Dutch study sought to add to what is known about the cost-effectiveness of shared decision-making in multiple sclerosis.

Dr Patricia Coyle on Considerations in Choosing a DMT for MS

November 29th 2020, 12:45pm


Multiple factors come into play when providers and patients discuss a disease-modifying therapy for multiple sclerosis (MS), explains Patricia K. Coyle, MD, of Stony Brook University Neurosciences Institute.

New Study Finds Higher Incidence of Bladder Cancer, but Not Others, in MS

November 25th 2020, 9:00pm


Prior research has found increased colon and breast cancer in patients with multiple sclerosis (MS), but that was not borne out in this current study.